{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:32:27Z","timestamp":1793280747210,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s11033-023-08608-w","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T09:01:31Z","timestamp":1688202091000},"page":"6843-6850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigation of XPD, miR-145 and miR-770 expression in patients with end-stage renal disease"],"prefix":"10.1007","volume":"50","author":[{"given":"Elif","family":"Citak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan Feyyaz","family":"Yalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Riza","family":"Altiparmak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8749-1708","authenticated-orcid":false,"given":"Mehmet","family":"Guven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"key":"8608_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.kisu.2017.07.004","volume":"2017","author":"GT Obrador","year":"2011","unstructured":"Obrador GT, Schultheiss UT, Kretzler M, Langham RG, Nangaku M, Pecoits-Filho R, Pollock C, Rossert J, Correa-Rotter R, Stenvinkel P, Walker R, Yang CW, Fox CS, K\u00f6ttgen A (2011) Genetic and environmental risk factors for chronic kidney disease. Kidney Int Suppl 2017:88\u2013106. https:\/\/doi.org\/10.1016\/j.kisu.2017.07.004","journal-title":"Kidney Int Suppl"},{"key":"8608_CR2","doi-asserted-by":"publisher","unstructured":"Rangel-L\u00f3pez A, Paniagua-Medina ME, Urb\u00e1n-Reyes M, Cortes-Arredondo M, Alvarez-Aguilar C, L\u00f3pez-Meza J, Ochoa-Zarzosa A, Lindholm B, Garc\u00eda-L\u00f3pez E, Paniagua JR (2013) Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study. Mutagenesis 28: 219 \u2013 25. https:\/\/doi.org\/10.1093\/mutage\/ges075","DOI":"10.1093\/mutage\/ges075"},{"key":"8608_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/gtmb.2012.0301","volume":"17","author":"GS -Guven","year":"2013","unstructured":"Guven GS, Altiparmak MR, Trabulus S, Yalin AS, Batar B, Tunckale A, Guven M (2013) Relationship between genomic damage and clinical features in dialysis patients. Genet Test Mol Biomarkers 17:202\u2013206. https:\/\/doi.org\/10.1089\/gtmb.2012.0301","journal-title":"Genet Test Mol Biomarkers"},{"key":"8608_CR4","doi-asserted-by":"publisher","unstructured":"Schupp N, Stopper H, Heidland (2016) DNA damage in chronic kidney disease: Evaluation of clinical biomarkers. Oxid Med Cell Longev 2016: 3592042. https:\/\/doi.org\/10.1155\/2016\/3592042","DOI":"10.1155\/2016\/3592042"},{"key":"8608_CR5","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1007\/s00018-021-03934-3","volume":"78","author":"A -Luciani","year":"2021","unstructured":"Luciani A, Denley MCS, Govers LP, Sorrentino V, Froese DS (2021) Mitochondrial DNA mutations in renal disease: an overview. Cell Mol Life Sci 78:6851\u20136867. https:\/\/doi.org\/10.1007\/s00018-021-03934-3","journal-title":"Cell Mol Life Sci"},{"key":"8608_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.ackd.2021.09.006","volume":"28","author":"S -Shirazian","year":"2021","unstructured":"Shirazian S, Starakiewicz P, Latcha S (2021) Cancer Screening in end-stage kidney disease. Adv Chronic Kidney Dis 28:502\u2013508e1. https:\/\/doi.org\/10.1053\/j.ackd.2021.09.006","journal-title":"Adv Chronic Kidney Dis"},{"key":"8608_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000013314","volume":"18","author":"S -Vamvakas","year":"1998","unstructured":"Vamvakas S, Bahner U, Heidlan A (1998) Cancer in end-stage renal disease: potential factors involved. Am J Nephrol 18:89\u201395. https:\/\/doi.org\/10.1159\/000013314","journal-title":"Am J Nephrol"},{"key":"8608_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000501356","volume":"50","author":"K -Hayashi","year":"2019","unstructured":"Hayashi K, Hishikawa A, Itoh H (2019) DNA damage repair and DNA methylation in the kidney. Am J Nephrol 50:81\u201391. https:\/\/doi.org\/10.1159\/000501356","journal-title":"Am J Nephrol"},{"key":"8608_CR9","doi-asserted-by":"publisher","first-page":"9239","DOI":"10.1158\/0008-5472.CAN-08-1310","volume":"68","author":"U -Schmid","year":"2008","unstructured":"Schmid U, Stopper H, Schweda F, Queisser N, Schupp N (2008) Angiotensin II induces DNA damage in the kidney. Cancer Res 68:9239\u20139246. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1310","journal-title":"Cancer Res"},{"key":"8608_CR10","doi-asserted-by":"publisher","first-page":"103126","DOI":"10.1016\/j.dnarep.2021.103126","volume":"103","author":"M -Duan","year":"2021","unstructured":"Duan M, Speer RM, Ulibarri J, Liu KJ, Mao P (2021) Transcription-coupled nucleotide excision repair: new insights revealed by genomic approaches. DNA Repair (Amst) 103:103126. https:\/\/doi.org\/10.1016\/j.dnarep.2021.103126","journal-title":"DNA Repair (Amst)"},{"key":"8608_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0921-8777(00)00051-3","volume":"461","author":"U -Vogel","year":"2000","unstructured":"Vogel U, Dybdahl M, Frentz G, Nexo BA (2000) DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes. Mutat Res 461:197\u2013210. https:\/\/doi.org\/10.1016\/s0921-8777(00)00051-3","journal-title":"Mutat Res"},{"key":"8608_CR12","doi-asserted-by":"publisher","first-page":"eabp9457","DOI":"10.1126\/sciadv.abp9457","volume":"8","author":"E -Compe","year":"2022","unstructured":"Compe E, Pangou E, Le May N, Elly C, Braun C, Hwang JH, Coin F, Sumara I, Choi KW, Egly JM (2022) Phosphorylation of XPD drives its mitotic role independently of its DNA repair and transcription functions. Sci Adv 8:eabp9457. https:\/\/doi.org\/10.1126\/sciadv.abp9457","journal-title":"Sci Adv"},{"key":"8608_CR13","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11255-021-02922-7","volume":"54","author":"B -Franczyk","year":"2022","unstructured":"Franczyk B, Gluba-Brz\u00f3zka A, Olszewski R, Parolczyk M, Rysz-G\u00f3rzy\u0144ska M, Rysz J (2022) miRNA biomarkers in renal disease. Int Urol Nephrol 54:575\u2013588. https:\/\/doi.org\/10.1007\/s11255-021-02922-7","journal-title":"Int Urol Nephrol"},{"key":"8608_CR14","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1007\/s11033-023-08433-1","volume":"50","author":"T -Mutlu","year":"2022","unstructured":"Mutlu T, Ozoran E, Trabulus DC, Talu CK, Erhan D, Mete M, Guven M (2022) Expression of genes related to iron homeostasis in breast cancer. Mol Biol Rep 50:5157\u20135163. https:\/\/doi.org\/10.1007\/s11033-023-08433-1","journal-title":"Mol Biol Rep"},{"key":"8608_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrm3822","volume":"15","author":"JA -Marteijn","year":"2014","unstructured":"Marteijn JA, Lans H, Vermeulen W, Hoeijmakers JH (2014) Understanding nucleotide excision repair and its roles in cancer and ageing. Nat Rev Mol Cell Biol 15:465\u2013481. https:\/\/doi.org\/10.1038\/nrm3822","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8608_CR16","doi-asserted-by":"publisher","first-page":"e24932","DOI":"10.4161\/rdis.24932","volume":"1","author":"HH -Kralund","year":"2013","unstructured":"Kralund HH, Ousager L, Jaspers NG, Raams A, Pedersen EB, Gade E, Bygum A (2013) Xeroderma Pigmentosum-Trichothiodystrophy overlap patient with novel XPD\/ERCC2 mutation. Rare Dis 1:e24932. https:\/\/doi.org\/10.4161\/rdis.24932","journal-title":"Rare Dis"},{"key":"8608_CR17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/nature08672","volume":"463","author":"GL -Dalgliesh","year":"2010","unstructured":"Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A et al (2010) Systematic sequencingn of renal carcinoma reveals inactivation of histone modifying genes. Nature 463:360\u2013363. https:\/\/doi.org\/10.1038\/nature08672","journal-title":"Nature"},{"key":"8608_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1620\/tjem.239.231","volume":"239","author":"D -Kondo","year":"2016","unstructured":"Kondo D, Noguchi A, Tamura H, Tsuchida S, Takahashi I, Kubot H, Yano T, Oyama C, Sawaishi Y, Moriwaki S, Takahashi T (2016) Elevated urinary levels of 8-Hydroxy-2\u2019-deoxyguanosine in a japanese child of Xeroderma Pigmentosum\/Cockayne Syndrome Complex with Infantile Onset of Nephrotic Syndrome. Tohoku J Exp Med 239:231\u2013235. https:\/\/doi.org\/10.1620\/tjem.239.231","journal-title":"Tohoku J Exp Med"},{"key":"8608_CR19","doi-asserted-by":"publisher","first-page":"503167","DOI":"10.1016\/j.mrgentox.2020.503167","volume":"852","author":"Z -Corredor","year":"2020","unstructured":"Corredor Z, da Silva Filho MI, Rodr\u00edguez-Ribera L, Catalano C, Hemminki K, Coll E, Silva I, Diaz JM, Ballarin JA, Hen\u00e1ndez A, F\u00f6rsti A, Marcos R, Pastor S (2020) Loci associated with genomic damage levels in chronic kidney disease patients and controls. Mutat Res Genet Toxicol Environ Mutagen 852:503167. https:\/\/doi.org\/10.1016\/j.mrgentox.2020.503167","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"8608_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3109\/0886022X.2014.967646","volume":"37","author":"WM -Radwan","year":"2015","unstructured":"Radwan WM, Elbarbary HS, Alsheikh NM (2015) DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in egyptian population. Ren Fail 37:122\u2013128. https:\/\/doi.org\/10.3109\/0886022X.2014.967646","journal-title":"Ren Fail"},{"key":"8608_CR21","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1681\/ASN","volume":"19","author":"S -Shi","year":"2008","unstructured":"Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P, Bottinger EP (2008) Podocyteselective deletion of dicer induces proteinuria and glomerulosclerosis. J Am Soc Nephrol 19:2159\u20132169. https:\/\/doi.org\/10.1681\/ASN.2008030312","journal-title":"J Am Soc Nephrol"},{"key":"8608_CR22","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1681\/ASN.2008020162","volume":"19","author":"J -Ho","year":"2008","unstructured":"Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA (2008) Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19:2069\u20132075. https:\/\/doi.org\/10.1681\/ASN.2008020162","journal-title":"J Am Soc Nephrol"},{"key":"8608_CR23","doi-asserted-by":"publisher","first-page":"e64558","DOI":"10.1371\/journal.pone.0064558","volume":"8","author":"NX -Chen","year":"2013","unstructured":"Chen NX, Kiattisunthorn K, O\u2019Neill KD, Chen X, Moorthi RN, Gattone VH, Allen MR, Moe SM (2013) Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS ONE 8:e64558. https:\/\/doi.org\/10.1371\/journal.pone.0064558","journal-title":"PLoS ONE"},{"key":"8608_CR24","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1111\/cas.14517","volume":"111","author":"W -Xu","year":"2020","unstructured":"Xu W, Hua Y, Deng F, Wang D, Wu Y, Zhang W, Tang J (2020) MiR-145 in cancer therapy resistance and sensitivity: a comprehensive review. Cancer Sci 111:3122\u20133131. https:\/\/doi.org\/10.1111\/cas.14517","journal-title":"Cancer Sci"},{"key":"8608_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.toxlet.2018.04.028","volume":"295","author":"S -Wei","year":"2018","unstructured":"Wei S, Xue J, Sun B, Zou Z, Chen C, Liu Q, Zhang A (2018) miR-145 via targeting ERCC2 is involved in arsenite-induced DNA damage in human hepatic cells. Toxicol Lett 295:220\u2013228. https:\/\/doi.org\/10.1016\/j.toxlet.2018.04.028","journal-title":"Toxicol Lett"},{"key":"8608_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40560-022-00637-0","volume":"10","author":"T -Phulkerd","year":"2022","unstructured":"Phulkerd T, Lertussavavivat T, Limothai U, Peerapornratana S, Kulvichit W, Lumlertgul N, Tungsanga K, Eiam-Ong S, Avihingsanon Y, Srisawat N (2022) Circulating and urinary microRNAs profile for predicting renal recovery from severe acute kidney injury. J Intensive Care 10:45. https:\/\/doi.org\/10.1186\/s40560-022-00637-0","journal-title":"J Intensive Care"},{"key":"8608_CR27","doi-asserted-by":"publisher","unstructured":"Park S, Moon S, Lee K, Park IB, Lee DH, Nam S (20189 urinary and blood microRNA-126 and \u2013 770 are potential noninvasive biomarker candidates for diabetic nephropathy: a meta-analysis. Cell Physiol Biochem 46: 1331\u20131340. https:\/\/doi.org\/10.1159\/000489148","DOI":"10.1159\/000489148"},{"key":"8608_CR28","doi-asserted-by":"publisher","first-page":"BSR20193653","DOI":"10.1042\/BSR20193653","volume":"40","author":"L -Wang","year":"2020","unstructured":"Wang L, Li H (2020) MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3. Biosci Rep 40:BSR20193653. https:\/\/doi.org\/10.1042\/BSR20193653","journal-title":"Biosci Rep"},{"key":"8608_CR29","doi-asserted-by":"publisher","first-page":"53254","DOI":"10.18632\/oncotarget.10736","volume":"7","author":"H -Zhao","year":"2016","unstructured":"Zhao H, Yu X, Ding Y, Zhao J, Wang G, Wu X, Jiang J, Peng C, Guo GZ, Cui S (2016) MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2. Oncotarget 7:53254\u201353268. https:\/\/doi.org\/10.18632\/oncotarget.10736","journal-title":"Oncotarget"},{"key":"8608_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mrgentox.2008.08.004","volume":"657","author":"PB -Bagatini","year":"2008","unstructured":"Bagatini PB, Palazzo RP, Rodrigues MT, Costa CH, Maluf SW (2008) Induction and removal of DNA damage in blood leukocytes of patients with type 2 diabetes mellitus undergoing hemodialysis. Mutat Res 657:111\u2013115. https:\/\/doi.org\/10.1016\/j.mrgentox.2008.08.004","journal-title":"Mutat Res"},{"key":"8608_CR31","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/10715760400011452","volume":"38","author":"C -Muller","year":"2004","unstructured":"Muller C, Eisenbrand G, Gradinger M, Rath T, Albert FW, Vienken J, Singh R, Farmer PB, Stockis JP, Janzowski C (2004) Effects of hemodialysis, dialyser type and iron infusion on oxidative stress in uremic patients. Free Radic Res 38:1093\u20131100. https:\/\/doi.org\/10.1080\/10715760400011452","journal-title":"Free Radic Res"},{"key":"8608_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1159\/000519881","volume":"51","author":"M -Comoglu","year":"2022","unstructured":"Comoglu M, Dede F, Yenigun EC, Topcuoglu C, Inan O, Sahiner ES, Ates I (2022) Effects of medium cutoff membranes on pro-inflammatory cytokine and oxidative marker levels in patients with sepsis who developed acute kidney injury. Blood Purif 51:772\u2013779. https:\/\/doi.org\/10.1159\/000519881","journal-title":"Blood Purif"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08608-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08608-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08608-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T12:19:28Z","timestamp":1690460368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08608-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["8608"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08608-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2777242\/v1","asserted-by":"object"}]},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethical approval was obtained from Istanbul University-Cerrahpasa Cerrahpasa Medical School Institutional Review Board with the serial code of 23,992. All of the procedures on human participants were in accordance with the declaration of Helsinki in 1964, its ammendments and parallel ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the patients in this study provided informed consent before inclusion.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}